Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Cash (2019 - 2025)

Pulmonx (LUNG) has disclosed Change in Cash for 7 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • Quarterly Change in Cash rose 818.54% to $1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 million through Sep 2025, up 141.88% year-over-year, with the annual reading at -$12.6 million for FY2024, 30.58% up from the prior year.
  • Change in Cash for Q3 2025 was $1.1 million at Pulmonx, up from $913000.0 in the prior quarter.
  • The five-year high for Change in Cash was $8.7 million in Q1 2023, with the low at -$39.6 million in Q4 2021.
  • Average Change in Cash over 5 years is -$8.2 million, with a median of -$8.6 million recorded in 2023.
  • The sharpest move saw Change in Cash plummeted 1406.63% in 2021, then surged 818.54% in 2025.
  • Over 5 years, Change in Cash stood at -$39.6 million in 2021, then surged by 73.06% to -$10.7 million in 2022, then dropped by 6.85% to -$11.4 million in 2023, then skyrocketed by 166.61% to $7.6 million in 2024, then crashed by 85.71% to $1.1 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at $1.1 million, $913000.0, and $3.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.